A clear and complete explanation of the FACTA Technology emerged within the interview realized by TelePadova to Alessandro Gandaglia (CEO of BCI). Check the full interview:
A Made in Italy technology that allows the doubling of the life of biological heart valves. The solution was developed by BCI, the innovative company led […]
«The Italian startup BCI – BioCompatibility has developed a new technology which is able to double the duration of biological heart valves thanks to the implementation […]
In the interview with Caffè Europa, on Rai Radio 1, Alessandro Gandaglia, biologist and co-founder, together with Filippo Naso and Ugo Stefanelli, of BCI (BioCompatibility Innovation), […]
«Our company BCI has entered into negotiations with the two main industrial partners in the field of biological heart valves – in terms of sales volume» […]